|
LTRN Lantern Pharma Inc 1763950 |
| Income Statement |
|
Net Income
|
form10-q
|
-4,505,697 |
| Balance Sheet |
|
Current Assets
|
29,920,960 |
|
Assets
|
30,293,264 |
|
Current Liabilities
|
3,601,090 |
|
Liabilities
|
3,695,043 |
|
Equity
|
26,598,221 |
|
Shares Out
|
10,765,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-13,841,414 |
|
Investing Cash Flow
|
-77,886 |
| Market Analysis |
Market Cap
|
42,251,525 |
|
Price
|
3.75 |
|
BVPS
|
2.47 |
|
PB
|
1.54 |
|
EPS
|
-1.65 |
|
PS
|
3.07 |
|
FCF
|
-13,919,300 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view LTRN documents filed with the SEC.
LTRN Filings
Clear
